tirzepatide and metformin together for weight loss Mounjaro Metformin: A Head-to-Head Comparison Metformin + Tirzepatide for Weight

Of the 2,570 MOUNJARO-treated patients who developed anti-tirzepatide antibodies during the treatment periods in these seven trials, 2% and 2% developed neutralizing antibodies against tirzepatide activity on the GIP or GLP-1 receptors, respectively, and 0.9% and 0.4% developed neutralizing antibodies against native GIP or GLP-1, respectively

Qian, M., Wu, N., Li, L., Yu, W., Ouyang, H., Liu, X., He, Y., & Al-Mureish, A

The results suggest that these medications positive effects extend beyond weight management, promoting overall health improvements

While these medications are potent, determining their strength can be complex, as its not just about their half-life or the amount of the active ingredient